Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 11
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
This article has a correction. Please see:
Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds - December 01, 2021
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Online download statistics by month:
Online download statistics by month: November 2021 to February 2024
Abstract
Full
Pdf
Nov 2021
12
625
160
Dec 2021
373
391
155
Jan 2022
223
262
94
Feb 2022
168
187
68
Mar 2022
137
143
76
Apr 2022
124
138
58
May 2022
146
160
62
Jun 2022
180
195
54
Jul 2022
141
147
48
Aug 2022
125
131
39
Sep 2022
104
108
64
Oct 2022
118
119
42
Nov 2022
114
116
44
Dec 2022
73
74
26
Jan 2023
95
98
49
Feb 2023
133
133
66
Mar 2023
125
130
58
Apr 2023
66
68
37
May 2023
67
68
40
Jun 2023
64
64
45
Jul 2023
76
76
32
Aug 2023
71
71
21
Sep 2023
165
167
12
Oct 2023
87
87
21
Nov 2023
80
81
17
Dec 2023
58
60
30
Jan 2024
42
43
29
Feb 2024
75
75
44
Total
3242
4017
1491
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?